Skip to main content
. 2021 Nov 9;13:8387–8397. doi: 10.2147/CMAR.S330019

Figure 7.

Figure 7

LINC01614 promote bladder cancer progression through RUNX2/Wnt/β-catenin axis.

Notes: (A) The RUNX2 expression in sh-LINC01614 and sh-LINC01614+RUNX2-OE cells, ***P < 0.001; (B) CCK8 assay was performed in sh-NC, sh-LINC01614 and sh-LINC01614+RUNX2-OE cells, **P < 0.01; (C) colony formation assay was performed in sh-NC, sh-LINC01614 and sh-LINC01614+RUNX2-OE cells, ***P < 0.001; (D) transwell assay was conducted in sh-NC, sh-LINC01614 and sh-LINC01614+RUNX2-OE cells, ***P < 0.001; (E) EdU assay was performed in the sh-NC, sh-LINC01614 and sh-LIC01614+RUNX2-OE cells, ***P < 0.001; (FH) Western blot was used to detect the marker of Wnt/β-catenin pathway and RUNX2 in different groups, NS. P> 0.05, ***P < 0.001.